Alvotech proposed biosimilar to Stelara accepted by EMA
The companies anticipate that the EMA could also recommend marketing authorisation for AVT04
Read More
Tag: biosimilar
Celltrion’s infliximab biosimilar to be tested for COVID-19
Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety profile
Read More
Mundipharma picks up rights to Herceptin biosimilar Tuznue
The deals allows the firm to market and distribute the drug in selected European countries following its approval
Read More
EMA gives trastuzumab biosimilar Marketing Authorisation Application
The drug is Prestige’s lead development candidate biosimilar to Roche’s Herceptin.
Read More
Long-term data shows promise in breast cancer biosimilar
The a three-year follow-up study comparing Ontruzant to Herceptin has found the biosimilar to be just as successful.
Read More
Napp launches pegfilgrastim biosimilar in the UK
Napp Pharmaceuticals has launched Pelmeg – a pegfilgrastim biosimilar – across the UK.
Read More
Mundipharma launches Pelmeg biosimilar in Europe
Mundipharma has announced the launch of Pelmeg (pegfilgrastim), a biosimilar of Neulasta, following its European Commission (EC) approval in November 2018.
Read More
NHS set to save record £300 million on highest drug spend
The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low-cost versions of the health service’s most costly drug.
Read More
EU OKs Mundipharma’s Neulasta biosimilar
The Mundipharma network of independent associated companies says European regulators have approved use of Pelmeg, a biosimilar of Amgen’s white blood cell booster Neulasta.
Read More
Another Humira biosimilar hits EU shores
Samsung Bioepis has announced the European launch of Humira biosimilar Imraldi, as NHS chiefs tell Trusts to ensure they are ready to realise the potential savings from using cheaper versions of the world’s biggest selling drug.
Read More
Amgen begins rolling out Humira biosimilar in the EU
Amgen has begun launching Amgevita, the first biosimilar of AbbVie’s anti-inflammatory blockbuster Humira to win approval in Europe, across the region.
Read More
EU green light for new Humira biosimilar
The European Commission has approved Mylan and Fujifilm Kyowa Kirin Biologics’ Humira biosimiar Hulio.
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
